Iron Triangle Partners LP
- SEC CIK
- 0001779763
- Latest filing
- Feb 17, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 28
- +2 vs. Q4 2023
- Portfolio value
- $966.4M
- +$193.5M (+25.0%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ACHCAcadia Healthcare Company, Inc. | COM | 902,813 | $71.5M | 7.4% | +110,820+14.0% | Added | History |
| DXCMDexcom Inc | COM | 471,631 | $65.4M | 6.8% | +181,631+62.6% | Added | History |
| ICLRIcon PLC | COM | 150,853 | $50.7M | 5.2% | −21,822−12.6% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 276,098 | $50.3M | 5.2% | +26,098+10.4% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 124,337 | $49.6M | 5.1% | +4,337+3.6% | Added | History |
| EXASExact Sciences Corp | COM | 700,000 | $48.3M | 5.0% | +700,000 | New | History |
| WSTWest Pharmaceutical Services Inc | COM | 119,736 | $47.4M | 4.9% | +119,736 | New | History |
| ALGNAlign Technology Inc | COM | 141,958 | $46.6M | 4.8% | +141,958 | New | History |
| ILMNIllumina, Inc. | COM | 330,758 | $45.4M | 4.7% | +110,758+50.3% | Added | History |
| BRKRBruker Corp | COM | 466,521 | $43.8M | 4.5% | +16,521+3.7% | Added | History |
| GKOSGLAUKOS Corp | COM | 429,525 | $40.5M | 4.2% | +184,919+75.6% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 2,769,864 | $39.1M | 4.0% | +1,469,864+113.1% | Added | History |
| BKDBrookdale Senior Living Inc. | COM | 5,897,960 | $39.0M | 4.0% | +1,038,353+21.4% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 550,000 | $32.3M | 3.3% | +550,000 | New | History |
| FTREFortrea Holdings Inc. | COMMON STOCK | 791,233 | $31.8M | 3.3% | +791,233 | New | History |
| NBIXNeurocrine Biosciences Inc | Stock | 220,000 | $30.3M | 3.1% | +220,000 | New | History |
| AVTRAvantor, Inc. | COM | 1,150,000 | $29.4M | 3.0% | +1,150,000 | New | History |
| SWAVShockwave Medical, Inc. | COM | 79,736 | $26.0M | 2.7% | +79,736 | New | History |
| SDGRSchrodinger, Inc. | COM | 863,323 | $23.3M | 2.4% | +394,738+84.2% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 973,057 | $23.2M | 2.4% | +973,057 | New | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 226,066 | $21.5M | 2.2% | +226,066 | New | – |
| ELANElanco Animal Health Inc | COM | 1,297,132 | $21.1M | 2.2% | −1,702,868−56.8% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 300,000 | $21.0M | 2.2% | +300,000 | New | History |
| MCKMcKesson Corp | Stock | 37,419 | $20.1M | 2.1% | −42,581−53.2% | Reduced | History |
| OSCROscar Health, Inc. | CL A | 1,334,503 | $19.8M | 2.1% | −718,048−35.0% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 45,000 | $17.7M | 1.8% | +45,000 | New | History |
| MASS908 Devices Inc. | COM | 1,040,768 | $7.86M | 0.8% | −244,179−19.0% | Reduced | History |
| NYXHNyxoah SA | COMMONSTOCK | 253,025 | $3.41M | 0.4% | +253,025 | New | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ELANElanco Animal Health Inc | COM | – | $9.94M |
Sold out since Q4 2023 (11)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| UHSUniversal Health Services Inc | CL B | 321,886 | $49.1M | 6.3% | History |
| IDXXIDEXX Laboratories Inc | COM | 76,025 | $42.2M | 5.5% | History |
| SGRYSurgery Partners, Inc. | Stock | 1,044,530 | $33.4M | 4.3% | History |
| INSPInspire Medical Systems, Inc. | COM | 150,000 | $30.5M | 3.9% | History |
| TXG10x Genomics, Inc. | CL A COM | 479,374 | $26.8M | 3.5% | History |
| SNYSanofi | SPONSORED ADR | 500,000 | $24.9M | 3.2% | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 380,000 | $22.9M | 3.0% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 200,000 | $19.3M | 2.5% | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,843,278 | $18.1M | 2.3% | History |
| RGENRepligen Corp | COM | 82,537 | $14.8M | 1.9% | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 331,238 | $8.58M | 1.1% | History |